Navigation Links
Environmental Tectonics Corporation Announces the Placement of Two Monoplace Hyperbaric Chambers at Saint Barnabas Medical Center in New Jersey
Date:10/6/2008

SOUTHAMPTON, Pa., Oct. 6 /PRNewswire-FirstCall/ -- Environmental Tectonics Corporation's (Amex: ETC) ("ETC" or the "Company") BioMedical Systems Division today announced the sale of two (2) BARA-MED(R) XD Monoplace Hyperbaric Chambers to Saint Barnabas Medical Center, Livingston, NJ.

ETC is delighted to work with Saint Barnabas Medical Center, New Jersey's oldest nonprofit, nonsectarian hospital. The 597-bed institution is one of the largest health care providers in the state.

Eric Carney, Assistant Vice President of Ambulatory Services for Saint Barnabas, stated "ETC was the clear choice as the BARA-MED XD allows for better patient comfort in both size and design. ETC has unsurpassed technology in their operating and recordkeeping system and I like how they are continuing the technological trend with the integration of their computer software with other wound care software providers."

The BARA-MED(R) XD Monoplace Hyperbaric Chambers are used in Hyperbaric Oxygen Therapy (HBO), which is a non-invasive procedure where the patient breathes 100% oxygen while fully enclosed in a specially designed chamber at increased atmospheric pressure. HBO is the primary treatment for carbon monoxide poisoning, arterial gas embolism and decompression sickness. It is also used to promote and support healing in the management of conditions in which oxygen transport to the tissues has been disrupted by traumatic injury, infection, inflammation, or edema.

ETC is the world's only manufacturer of a computerized monoplace hyperbaric chamber. The BARA-MED(R) XD includes a 4th generation Windows(TM) based operating system with O.S.C.A.R. (TM) (Operating System for Control And Recordkeeping). With O.S.C.A.R. (TM) on your team, you eliminate the need for operator dive time management and paper recordkeeping while ensuring comprehensive documentation of the procedure. These features enable technicians to focus their attention on patient care and management, making your team more effective and efficient.

Bob Salmons, North Eastern U. S. Regional Manager for the BioMedical Division, commented, "We are finding more hospitals are turning to our technology in preparation of the upcoming changes in EMR (Electronic Medical Recordkeeping)."

ETC's BioMedical Systems Division's goal is to continue to be at the forefront of hyperbaric medicine and EMR with innovative new products and features like O.S.C.A.R. (TM).

ETC designs, develops, installs and maintains aircrew training systems (aeromedical, tactical combat and general), disaster management training systems and services, entertainment products, sterilizers (steam and gas), environmental testing products, hyperbaric chambers and related products for domestic and international customers.

This press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements are based on ETC's current expectations and projections about future events. These forward-looking statements are subject to known and unknown risks, uncertainties and assumptions about ETC's and its subsidiaries that may cause actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements.

These forward-looking statements include statements with respect to the Company's vision, mission, strategies, goals, beliefs, plans, objectives, expectations, anticipations, estimates, intentions, financial condition, results of operations, future performance and business of the company, including but not limited to, (i) the potential delisting of the Company's common stock from the American Stock Exchange as a result of the Company's failure to comply with the AMEX listing standards, (ii) projections of revenues, costs of materials, income or loss, earnings or loss per share, capital expenditures, growth prospects, dividends, capital structure, other financial items and the effects of currency fluctuations, (iii) statements of our plans and objectives of the Company or its management or Board of Directors, including the introduction of new products, or estimates or predictions of actions of customers, suppliers, competitors or regulatory authorities, (iv) statements of future economic performance, (v) statements of assumptions and other statements about the Company or its business, (vi) statements made about the possible outcomes of litigation involving the Company, including our outstanding litigation with Disney; (vii) statements regarding the Company's ability to obtain financing to support its operations and other expenses, and (viii) statements preceded by, followed by or that include the words, "may," "could," "should," "looking forward," "would," "believe," "expect," "anticipate," "estimate," "intend," "plan," or the negative of such terms or similar expressions. These forward-looking statements involve risks and uncertainties which are subject to change based on various important factors. Some of these risks and uncertainties, in whole or in part, are beyond the Company's control. Factors that might cause or contribute to such a material difference include, but are not limited to, those discussed in the Company's Annual Report on Form 10-K for the fiscal year ended February 29, 2008, in the section entitled "Risks Particular to Our Business." Shareholders are urged to review these risks carefully prior to making an investment in the Company's common stock.

The Company cautions that the foregoing list of important factors is not exclusive. Except as required by federal securities law, the Company does not undertake to update any forward-looking statement, whether written or oral, that may be made from time to time by or on behalf of the Company.

Contact: Duane D. Deaner, CFO

Tel: 215-355-9100 (ext. 1203) Fax: 215-357-4000

ETC - Internet Home Page: http://www.etcusa.com


'/>"/>
SOURCE Environmental Tectonics Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Bion Announces Approval of New Australian Patent for Low Oxygen Organic Waste Bioconversion for Livestock Waste Environmental Treatment
2. Environmental Tectonics Corporation Announces a Multiple Sale for Monoplace Hyperbaric Chambers
3. Environmental Tectonics Corporations Sterilization Systems Group Announces New Contracts
4. Bion Announces Approval of New U.S. Patent for Phosphorus Removal Process for Livestock Waste Environmental Treatment
5. Carbon hoofprint: Cows supplemented with rbST reduce agricultures environmental impact
6. Bion Outlines Differences between its Patented Comprehensive Livestock Environmental Treatment Technology and Anaerobic Digesters
7. Environmental Power Holds Ground Breaking Ceremony for Renewable Natural Gas Facility at Rio Leche Estates
8. Environmental Tectonics Corporations BioMedical Systems Division Awarded Contract for Multiple Monoplace Chambers
9. Environmental Tectonics Corporations BioMedical Division Announces Sale of Two Hyperbaric Chambers
10. Startech Environmental to Have Three Plasma Converters in Former Pharmaceutical Industry Facility in Puerto Rico
11. Citrate appears to control buckyball clumping but environmental concerns remain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... ... February 08, 2016 , ... Information Management Services ( ... The upgrade represents a completely new technical foundation and is so significant it ... responsive design interface, significantly increased speed for search results, a streamlined layout and a ...
(Date:2/8/2016)... -- Diplomat Pharmacy, Inc. (NYSE: DPLO) announced today that its new website has gone live. On Thursday, ... mobile-friendly. Visit the new site: www.diplomat.is ... ... ... "The goal was to reimagine the website and create ...
(Date:2/5/2016)... , Feb. 5, 2016  In the pharmaceutical industry ... a host of launch activities including the identification and ... launch activity is especially high in the oncology therapeutic ... Best Practices and the Role of Medical Affairs in ... focused on oncology therapies find better ways to utilize ...
(Date:2/4/2016)... - New FDA action date of July ... action date of July 22, 2016   --> ... 22, 2016   - Lifitegrast has the ... for the treatment of signs and symptoms of dry eye disease ... to be the only product approved in the U.S. in the past decade indicated for ...
Breaking Biology Technology:
(Date:2/2/2016)... Feb. 2, 2016  BioMEMS devices deployed ... focused on medical screening and diagnostic applications, ... Wearable devices that facilitate and assure continuous ... movement are being bolstered through new opportunities ... signal acquisition coupled with wireless connectivity and ...
(Date:2/2/2016)... , Feb. 2, 2016 Technology Enhancements Accelerate ... an analysis of the digital and computed radiography markets ... , and Indonesia (TIM). ... and market size, as well as regional market drivers ... and discusses market penetration and market attractiveness, both for ...
(Date:2/1/2016)... Rising sales of consumer electronics ... intuitive gesture control market size ... consumer electronics coupled with new technological advancements to drive ... through 2020   --> ... advancements to drive global touchfree intuitive gesture control market ...
Breaking Biology News(10 mins):